Demand articulation in emerging technologies Wouter Boon, Ellen Moors Athena Institute, VU University Amsterdam Third International Seville Conference.

Slides:



Advertisements
Similar presentations
European Social Dialogue in the Chemical Industry Reinhard Reibsch Secretary General EMCEF HLG Follow-up-Conference Usti and Labem.
Advertisements

Active ageing into practice! Experiences of civic engagement in health policies Alessio Terzi, Teresa Petrangolini, Giulia Savarese Cittadinanzattiva.
1 HAI conference Medicines for Europe and the World Setting priorities: missing the point A rational medicines policy for Europe A rational.
Creating a Window of Opportunity for Policy Change By Nancy Yinger, The Population Reference Bureau AMDD Conference Kuala Lumpur, 2003.
TRI science addiction Lost Opportunity? SBI for Substance Abuse In ERs and Trauma Centers Academy Health Mady Chalk, Ph.D. Treatment Research Institute.
The Role of Welsh Health Libraries in Supporting Information Provision to NHS Users Anne Cleves AWHILES Conference 14 th July 2009.
European Network on Roma Community and Social Inclusion Proposal for the Operational and Organisational Structure Sevilla, 24 & 25 January 2008.
EPAN - Workshop eGovernment : People and Skills Introduction – Luxembourg Presidency NL – Maastricht, 24 June 2005.
Second International Seville Seminar on Future-Oriented Technology Analysis (FTA): Impacts on policy and decision making 28th- 29th September 2006 Responsibility.
EURADWASTE 29 March 2004 LOCAL COMMUNITIES IN NUCLEAR WASTE MANAGEMENT THE COWAM EUROPEAN PROJECT EURADWASTE, 29 March 2004.
FTA-Approaches integrated in the broader SPI Context Improving Regional RTDI Policies & Investments *G. Clar, **H. Acheson, *S. Hafner-Zimmermann, *B.
Normative-narrative scenarios as a tool to support strategic R&D processes: benefits and limits Hannah Kosow, Dr. Robert Gaßner IZT – Institute for Futures.
1 Bridging long-term scenario and strategy analysis: current practice and future directions in environmental policy The 3rd International Seville Conference.
Real-Time Delphi as a Tool for Scenarios Building: a case report on an aeronautical firm Denis L. Balaguer José Eduardo de C. Bezerra Rodrigo C. da Silva.
Consistent context scenarios: a new approach to ‘story and simulation’
FOREST EUROPE Preparing the Sixth Ministerial Conference, including a possible legal instrument on forests EFI Annual Conference 15 September 2010, Dresden,
28 th November 2005 JISC VRE Consultation Workshop What is happening, what are the likely outcomes, what is the likely impact, what does it all mean? John.
THE CARERS RESEARCH PARTNERSHIP Elizabeth McDade.
Promoting Innovative Intermodal Freight Transport PROMIT 5 th Workshop, Bologna, 20/21 November 2007 PROMIT Co-ordination Action Promoting Innovative Intermodal.
Impact of the evaluations and follow-up activities M. Assunção, 13 October 2008 EUA Institutional Evaluation Programme, Workshop for Universities: round.
Dublin Airport Stakeholders Forum Workshop 28 November 2007.
EHR stakeholder workshop – 11th October EHR integration for clinical research: toward new interaction models ? Isabelle de Zegher.
Fostering R&D and Promoting Access to Medicines (for all) From Alma Ata, via Doha to Geneva (in 10 minutes) Bellagio, Italy October 2007 Ellen ‘t.
Healthcare Interpretation Network Trained Interpreters – an Important Member of the Care Team: The careprovider’s perspective Grace Eagan, MA UHN Interpretation.
The Use and Impact of FTA Attila Havas and Ron Johnston Institute of Economics, Hungarian Academy of Sciences, and Australian Centre for Innovation Third.
Case study: The National Library for Health (NLH) Specialist Libraries An example of a Community of Practice.
Promoting patient-centred healthcare around the world A patient perspective on the multiple policy initiatives: Lessons learnt – assessing the gaps Joanna.
PUBLIC HEALTH INNOVATION AND RESEARCH IN EUROPE AND THE UNITED KINGDOM EXPLORING THE BREADTH OF PUBLIC HEALTH RESEARCH FPH ANNUAL CONFERENCE 2012, CARDIFF.
A Model of eHealth Interoperability Craig Kuziemsky, Telfer School of Mgmt, University of Ottawa. James Williams, Community Care Information Management.
1 Improving School Leadership - Guidelines for Country Background Reports - Education and Training Policy Division Directorate of Education.
Goal-oriented modulation as a model for dealing with problems of sustainable development René Kemp UNU-MERIT, ICIS & DRIFT.
The Key Role of Charities in Supporting Brain Research Marie Downes, MRCG Development Executive Brain Research in Ireland: Delivering on the Potential.
IT Governance and Management
Implementing Patient Decision Aids in Clinical Practice October 2014 Dawn Stacey RN, PhD Research Chair in Knowledge Translation to Patients Full Professor,
Martinuzzi, Steurer: Analysis of national policies on CSR CSR HLG Meeting on May 30, 2006 Analysis of national policies on CSR, in support of a structured.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
1 Evidence and the next stage of health care reform: Why consumer engagement is so important Steven D. Pearson, MD, MSc President, Institute for Clinical.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
The Role of Patients in EU Policy Development European Health Forum Gastein October 2003 – Bad Gastein Presented by Erick Savoye Director of the European.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
BREAST HEALTH GLOBAL INITIATIVE(BHGI) SUPPORTIVE CARE GUIDELINES& THEIR ROLE IN ADVOCACY : The Uganda Experience Gertrude Nakigudde Patient Advocate Uganda.
Canadian Cancer Society Manitoba Division: Knowledge Exchange Network (KEN) & CancerCare Manitoba Manitoba Integrated Chronic Disease Primary Prevention.
Séance académique - Academische zitting Collèges de Médecins - Colleges van Geneesheren Feedback en perspectieven Feed-back et perspectives Introduction.
Presentation by Lia van Ginneken – EMP Secretary & João Salazar – EMP Chairman 21st February 2009.
11 Whither EC Aid? Towards a new approach for the assessment of development cooperation Introduction to the process and Key emerging issues Gwénaëlle Corre.
Potential Roles for Health Technology Assessment Agencies: Opportunities and Challenges for an Effective Health Technology Assessment Practice at the Meso.
Thinking about research impact contributing to society and the economy Tara Fenwick (reflecting ESRC influence but not representing it!)
Meier F., Braun M., Ried J., Dabrock P., (2015): [Healthy or ill? Patients between technologies of the self and blurred identities] Dabrock P, Braun M,
European strategies for digitisation: the context of i2010 digital libraries Pat Manson Head of Unit Cultural Heritage and Technology Enhanced Learning.
The BMBF Foresight Process Kerstin Cuhls, Walter Ganz, Philine Warnke Fraunhofer ISI and Fraunhofer IAO Third International Seville Conference on Future-Oriented.
European Health Forum Gastein Workshop International Quality Comparisons 6 October 2005 "Measuring the patient's perspective: Current and future work in.
Caring, Ethics, Science. Caring Physicians of the World (CPW) Medical Leadership Communication and Medical Advocacy Course Monday, 2 nd May.
International Task Force Meeting on Sustainable Tourism Climate Change and Tourism United Nations Environment Programme Division of Technology, Industry.
By Dr. Talat AnwarAdvisor Centre for Policy Studies, CIIT, Islamabad Centre for Policy Studies, CIIT, Islamabad
INSPIRE and the role of Spatial Data Interest Communities (SDIC)
National Healthcare Technology Platform
Philine Warnke and Gaston Heimeriks IPTS
Order from Chaos: Improving Quality of Care in a Resident/Faculty Practice Through Integrated Team Meetings Jennifer Leiser, MD, Sonja Van Hala, MD, MPH,
Tools & Strategies Summary
MAES Working Group Meeting Brussels
Third International Seville Conference on Future-Oriented Technology Analysis (FTA): Impacts and implications for policy and decision-making 16th- 17th.
Supporting the Knowledge into Action Review May 2011
Rare Disease Impact Case
Patient Involvement in the Development and Use of Safe Medicines Introductory Section – Concepts to Consider CIOMS XI WG Second Meeting October 23-24,
The Use and Impact of FTA
WP2 Dissemination The dissemination process will mainly be based on 2 specific objectives: 1. Information delivery on the JARC 2. Dissemination of the.
Innovation programmes in the Netherlands
Proposal for a workshop on monitoring EURO-INBO 2013
New Approaches to Governance
Presentation transcript:

Demand articulation in emerging technologies Wouter Boon, Ellen Moors Athena Institute, VU University Amsterdam Third International Seville Conference on Future-Oriented Technology Analysis (FTA): Impacts and implications for policy and decision-making 16th- 17th October 2008

Demand articulation in emerging technologies Main conclusions Intermediary user organisations influence genomics innovation (translation) processes & debates, and vice versa Demand articulation processes are important learning processes about demands and underlying assumptions Intermediaries are loci of future-oriented technology assessment

Demand articulation in emerging technologies Demand articulation (1) A A A A A B Patient groups agenda Questions Needs Problems Ideas Expectations Promises ELSI concerns U/a Represented patients/members Other relevant parties

Demand articulation in emerging technologies Demand articulation (2) An iterative, inherently creative process in which stakeholders try to unravel preferences for and address what they perceive as important characteristics of an emerging innovation Learning process: demands (1st order) and underlying assumptions (2nd order) Followed by event history analysis (Van de Ven et al) time 1 st order: demands 2 nd order: underlying assumptions

Demand articulation in emerging technologies Research question How to understand the demand articulation processes of patient groups in the context of emerging pharmaceutical technologies?

Demand articulation in emerging technologies Case 1: Dutch Breast Cancer Association BVN Improve care for breast cancer patients Topic: reimbursement of expensive intramural breast cancer drugs (Herceptin)

Demand articulation in emerging technologies Case 1: Dutch Breast Cancer Association BVN Problem: reimbursement expensive drugs in hospitals Lot of organised actors articulate demands (solutions) Added problem: Herceptin use (no approval; medical guidelines)

Demand articulation in emerging technologies Case 2: Dutch Neuromuscular Diseases Association VSN Welfare, communication patients, stimulating research Topic: Pompe disease

Demand articulation in emerging technologies Case 2: Dutch Neuromuscular Diseases Association VSN : debates on use animals for drug production 2000: phase I/II involvement : compassionate use 2004: late-onset Pompe trials : reimbursement 2007: newborn screening

Demand articulation in emerging technologies Findings (1) 1 st order learning loop agenda synthesis expression evaluation 2 nd order learning loop self- position other- position Intermediary user organisation B B B A A A A A Examples: Expectations about specific emerging technologies Building science for Duchenne Dealing with alternative medicine and animal biotechnology Setting up clinical trials Reimbursement Compassionate use Concretise extent of problem of reimbursement Calls for action Examples: How to deal with emerging technology, How to manage expectations, and why? Setting-up activities Constant and also articulated because it wanted to copy the approach to other disease areas About dealing with R&D stimulation and steering; clinical trials; and policy regarding non-innovative drugs About balancing representation of patients About how to advocate 2 nd -order learning on objectives, values, frames and strategies indicates the development/maturing/periodisation of intermediaries

Demand articulation in emerging technologies Findings (2) 1 st order learning loop agenda synthesis expression evaluation 2 nd order learning loop self- position other- position Intermediary user organisation B B B A A A A A Demand articulation mechanisms: - Management of expectations - Knee-jerk reaction - Proactive network building - Pro/reactive case building

Demand articulation in emerging technologies Findings (3) 1 st order learning loop agenda synthesis expression evaluation 2 nd order learning loop self- position other- position Intermediary user organisation B B B A A A A A Two categories: - Silent majority - Patient champions

Demand articulation in emerging technologies Findings (4) 1 st order learning loop agenda synthesis expression evaluation 2 nd order learning loop self- position other- position Intermediary user organisation B B B A A A A A Interface strategies: - Access - Empowerment - Impact Examples: - Representation - Sudden anxiety Examples: - Unasked advocacy - Forceful advocacy - Alignment of actors

Demand articulation in emerging technologies Findings (5) 1 st order learning loop agenda synthesis expression evaluation 2 nd order learning loop self- position other- position Intermediary user organisation B B B A A A A A weighingorganisation feedback legitimise

Demand articulation in emerging technologies Organising demand articulation (1) Results from a workshop Workshop objective: create strategy how intermediary deal with steering pharmaceutical R&D Dutch federation of cancer patient organisations (NFK) Intermediaries as loci of future-oriented technology assessment?

Demand articulation in emerging technologies Organising demand articulation (2) Results from a workshop

Demand articulation in emerging technologies Identification of a list of important barriers and opportunities to involvement Recommendations of how to organise involvement, e.g.: – Professionalise, proactivity (active case building demand articulation mechanism) – Representation of members (advocate personal needs and anticipative alignment interface strategies) – Catalyst and form platform between actors (urging for action and network building demand articulation mechanisms) – Careful positioning (tentative interface strategies and considered self-positioning) In line with demand articulation mechanisms and interface strategies found in cases can be used to change intermediaries as loci of FTA Organising demand articulation (3) Results from a workshop

Demand articulation in emerging technologies Conclusions (1) Intermediary user organisations influence genomics innovation (translation) processes & debates, and vice versa Demand articulation processes are important learning processes about demands and underlying assumptions Intermediaries are loci of future-oriented technology assessment

Demand articulation in emerging technologies Conclusions (2) Three dilemmas: Positioning Representation Need to be proactive If overcome, intermediary user organisations can play central and crucial role

Demand articulation in emerging technologies Thank you for your attention! Questions and discussion